MedTrace Logo

Metabolic Changes as a Diagnostic Indicator for Cancer

NCT02362776 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 426

Last updated 2015-02-13

No results posted yet for this study

Summary

This study aims to determine whether metabolic changes occur in blood plasma of cancer patients, and whether these changes can be used as a biomarker to detect cancer. These analyses will be done by means of nuclear magnetic resonance (NMR) spectroscopy.

Conditions

Interventions

OTHER

Venous blood sample

Collection of a venous blood sample to investigate metabolic changes in blood

Sponsors & Collaborators

  • Ziekenhuis Oost-Limburg

    collaborator OTHER

  • Algemeen Ziekenhuis Vesalius

    collaborator OTHER

  • Ziekenhuis Maas en Kempen

    collaborator OTHER

  • Mariaziekenhuis Noord-Limburg

    collaborator OTHER

  • Hasselt University

    lead OTHER

Principal Investigators

  • Michiel Thomeer, prof. dr. · Ziekenhuis Oost-Limburg

  • Kurt Baeten, dr. · Hasselt University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02362776 on ClinicalTrials.gov